Copyright Reports & Markets. All rights reserved.

Global Prednisolone Market Size, Status and Forecast 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Prednisolone Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Tables
      • 1.4.3 Oral Solution
    • 1.5 Market by Application
      • 1.5.1 Global Prednisolone Market Share by Application (2014-2025)
      • 1.5.2 Inflammation
      • 1.5.3 Rheumatoid Arthritis
      • 1.5.4 Bell's Palsy
      • 1.5.5 Acute Lymphoblastic Leukemia
      • 1.5.6 Autoimmune Hepatitis
      • 1.5.7 Systemic Lupus Erythematosus
      • 1.5.8 Dermatomyositis
      • 1.5.9 Vasculitis
      • 1.5.10 Crohn's Disease
      • 1.5.11 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Prednisolone Market Size
    • 2.2 Prednisolone Growth Trends by Regions
      • 2.2.1 Prednisolone Market Size by Regions (2014-2025)
      • 2.2.2 Prednisolone Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Prednisolone Market Size by by Players
      • 3.1.1 Global Prednisolone Revenue by by Players (2014-2019)
      • 3.1.2 Global Prednisolone Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Prednisolone Market Concentration Ratio (CR5 and HHI)
    • 3.2 Prednisolone Key Players Head office and Area Served
    • 3.3 Key Players Prednisolone Product/Solution/Service
    • 3.4 Date of Enter into Prednisolone Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Prednisolone Market Size by Type (2014-2019)
    • 4.2 Global Prednisolone Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Prednisolone Market Size (2014-2019)
    • 5.2 Prednisolone Key Players in United States
    • 5.3 United States Prednisolone Market Size by Type
    • 5.4 United States Prednisolone Market Size by Application

    6 Europe

    • 6.1 Europe Prednisolone Market Size (2014-2019)
    • 6.2 Prednisolone Key Players in Europe
    • 6.3 Europe Prednisolone Market Size by Type
    • 6.4 Europe Prednisolone Market Size by Application

    7 China

    • 7.1 China Prednisolone Market Size (2014-2019)
    • 7.2 Prednisolone Key Players in China
    • 7.3 China Prednisolone Market Size by Type
    • 7.4 China Prednisolone Market Size by Application

    8 Japan

    • 8.1 Japan Prednisolone Market Size (2014-2019)
    • 8.2 Prednisolone Key Players in Japan
    • 8.3 Japan Prednisolone Market Size by Type
    • 8.4 Japan Prednisolone Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Prednisolone Market Size (2014-2019)
    • 9.2 Prednisolone Key Players in Southeast Asia
    • 9.3 Southeast Asia Prednisolone Market Size by Type
    • 9.4 Southeast Asia Prednisolone Market Size by Application

    10 India

    • 10.1 India Prednisolone Market Size (2014-2019)
    • 10.2 Prednisolone Key Players in India
    • 10.3 India Prednisolone Market Size by Type
    • 10.4 India Prednisolone Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Prednisolone Market Size (2014-2019)
    • 11.2 Prednisolone Key Players in Central & South America
    • 11.3 Central & South America Prednisolone Market Size by Type
    • 11.4 Central & South America Prednisolone Market Size by Application

    12 International Players Profiles

    • 12.1 Sanofi
      • 12.1.1 Sanofi Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Prednisolone Introduction
      • 12.1.4 Sanofi Revenue in Prednisolone Business (2014-2019)
      • 12.1.5 Sanofi Recent Development
    • 12.2 Symbiotec Pharma
      • 12.2.1 Symbiotec Pharma Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Prednisolone Introduction
      • 12.2.4 Symbiotec Pharma Revenue in Prednisolone Business (2014-2019)
      • 12.2.5 Symbiotec Pharma Recent Development
    • 12.3 Xianju Pharma
      • 12.3.1 Xianju Pharma Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Prednisolone Introduction
      • 12.3.4 Xianju Pharma Revenue in Prednisolone Business (2014-2019)
      • 12.3.5 Xianju Pharma Recent Development
    • 12.4 Wuhan DKY Technology
      • 12.4.1 Wuhan DKY Technology Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Prednisolone Introduction
      • 12.4.4 Wuhan DKY Technology Revenue in Prednisolone Business (2014-2019)
      • 12.4.5 Wuhan DKY Technology Recent Development
    • 12.5 Shandong Taihua Bio &Tech
      • 12.5.1 Shandong Taihua Bio &Tech Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Prednisolone Introduction
      • 12.5.4 Shandong Taihua Bio &Tech Revenue in Prednisolone Business (2014-2019)
      • 12.5.5 Shandong Taihua Bio &Tech Recent Development
    • 12.6 Mahima life Sciences
      • 12.6.1 Mahima life Sciences Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Prednisolone Introduction
      • 12.6.4 Mahima life Sciences Revenue in Prednisolone Business (2014-2019)
      • 12.6.5 Mahima life Sciences Recent Development
    • 12.7 Add Biotec
      • 12.7.1 Add Biotec Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Prednisolone Introduction
      • 12.7.4 Add Biotec Revenue in Prednisolone Business (2014-2019)
      • 12.7.5 Add Biotec Recent Development
    • 12.8 Henan Lihua Pharmaceutical
      • 12.8.1 Henan Lihua Pharmaceutical Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Prednisolone Introduction
      • 12.8.4 Henan Lihua Pharmaceutical Revenue in Prednisolone Business (2014-2019)
      • 12.8.5 Henan Lihua Pharmaceutical Recent Development
    • 12.9 Hunan Yuxin Pharmaceutical
      • 12.9.1 Hunan Yuxin Pharmaceutical Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Prednisolone Introduction
      • 12.9.4 Hunan Yuxin Pharmaceutical Revenue in Prednisolone Business (2014-2019)
      • 12.9.5 Hunan Yuxin Pharmaceutical Recent Development
    • 12.10 TEVA
      • 12.10.1 TEVA Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Prednisolone Introduction
      • 12.10.4 TEVA Revenue in Prednisolone Business (2014-2019)
      • 12.10.5 TEVA Recent Development
    • 12.11 Pfizer
    • 12.12 Pharmacia
    • 12.13 Sandoz
    • 12.14 Endo International
    • 12.15 Wockhardt

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Prednisolone market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Prednisolone status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prednisolone development in United States, Europe and China.

      The key players covered in this study
      Sanofi
      Symbiotec Pharma
      Xianju Pharma
      Wuhan DKY Technology
      Shandong Taihua Bio &Tech
      Mahima life Sciences
      Add Biotec
      Henan Lihua Pharmaceutical
      Hunan Yuxin Pharmaceutical
      TEVA
      Pfizer
      Pharmacia
      Sandoz
      Endo International
      Wockhardt

      Market segment by Type, the product can be split into
      Tables
      Oral Solution

      Market segment by Application, split into
      Inflammation
      Rheumatoid Arthritis
      Bell's Palsy
      Acute Lymphoblastic Leukemia
      Autoimmune Hepatitis
      Systemic Lupus Erythematosus
      Dermatomyositis
      Vasculitis
      Crohn's Disease
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Prednisolone status, future forecast, growth opportunity, key market and key players.
      To present the Prednisolone development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Prednisolone are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now